Profound Medical Corp. PROF NASDAQ

Profound Medical Corp. (PROF) reported exceptional year-over-year revenue growth of +51% through 2025-12 (TTM revenue vs prior-year TTM). The latest quarter net income was –$8M, with a YoY change of -56.1%. The net profit margin is -136.8%, which is negative. The company has not reported a profitable quarter in the last 4 quarters. The gross margin is 71.2% (high), up 5.7pp vs the prior year. With a market cap data available, MOAT composite score of 50/100 (moderate competitive position).

Criteria proven by this page:

• GROWTH (100/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (25/100, Fail) — the company has frequently reported losses. Looking at the full 12-year annual history, the company was profitable in 1 of 12 years — a mixed long-term record
• INCOME (100/100, Fail) — the company is currently operating at a loss
• MOAT (50/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 81/100 with 5/7 criteria passed.